255 related articles for article (PubMed ID: 33534626)
41. Review of vaccine hesitancy: Rationale, remit and methods.
Schuster M; Eskola J; Duclos P;
Vaccine; 2015 Aug; 33(34):4157-60. PubMed ID: 25896380
[TBL] [Abstract][Full Text] [Related]
42. COVID-19 Vaccination Strategies Considering Hesitancy Using Particle-Based Epidemic Simulation.
Karabay A; Kuzdeuov A; Varol HA
Annu Int Conf IEEE Eng Med Biol Soc; 2021 Nov; 2021():1985-1988. PubMed ID: 34891676
[TBL] [Abstract][Full Text] [Related]
43. 'Vaccine hesitancy' among university students in Italy during the COVID-19 pandemic.
Barello S; Nania T; Dellafiore F; Graffigna G; Caruso R
Eur J Epidemiol; 2020 Aug; 35(8):781-783. PubMed ID: 32761440
[TBL] [Abstract][Full Text] [Related]
44. Factors Associated With US Adults' Likelihood of Accepting COVID-19 Vaccination.
Kreps S; Prasad S; Brownstein JS; Hswen Y; Garibaldi BT; Zhang B; Kriner DL
JAMA Netw Open; 2020 Oct; 3(10):e2025594. PubMed ID: 33079199
[TBL] [Abstract][Full Text] [Related]
45. High but slightly declining COVID-19 vaccine acceptance and reasons for vaccine acceptance, Finland April to December 2020.
Hammer CC; Cristea V; Dub T; Sivelä J
Epidemiol Infect; 2021 May; 149():e123. PubMed ID: 33972001
[TBL] [Abstract][Full Text] [Related]
46. Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007-2012.
Larson HJ; Jarrett C; Eckersberger E; Smith DM; Paterson P
Vaccine; 2014 Apr; 32(19):2150-9. PubMed ID: 24598724
[TBL] [Abstract][Full Text] [Related]
47. Assessing the Level and Determinants of COVID-19 Vaccine Confidence in Kenya.
Orangi S; Pinchoff J; Mwanga D; Abuya T; Hamaluba M; Warimwe G; Austrian K; Barasa E
Vaccines (Basel); 2021 Aug; 9(8):. PubMed ID: 34452061
[TBL] [Abstract][Full Text] [Related]
48. COVID-19 Vaccine Hesitancy-A Scoping Review of Literature in High-Income Countries.
Aw J; Seng JJB; Seah SSY; Low LL
Vaccines (Basel); 2021 Aug; 9(8):. PubMed ID: 34452026
[TBL] [Abstract][Full Text] [Related]
49. Tracking government spending on immunization: The joint reporting forms, national health accounts, comprehensive multi-year plans and co-financing data.
Ikilezi G; Bachmeier SD; Cogswell IE; Maddison ER; Stutzman HN; Tsakalos G; Brenzel L; Dieleman JL; Micah AE
Vaccine; 2021 Jun; 39(25):3410-3418. PubMed ID: 34020816
[TBL] [Abstract][Full Text] [Related]
50. Prevalence and factors associated with covid-19 vaccine hesitancy in Maranhão, Brazil.
Oliveira BLCA; Campos MAG; Queiroz RCS; Alves MTSSBE; Souza BF; Santos AMD; Silva AAMD
Rev Saude Publica; 2021; 55():12. PubMed ID: 33909868
[TBL] [Abstract][Full Text] [Related]
51. Using Best Practices to Address COVID-19 Vaccine Hesitancy: The Case for the Motivational Interviewing Approach.
Gabarda A; Butterworth SW
Health Promot Pract; 2021 Sep; 22(5):611-615. PubMed ID: 33966471
[TBL] [Abstract][Full Text] [Related]
52. Willingness to Be Vaccinated against COVID-19 in Spain before the Start of Vaccination: A Cross-Sectional Study.
Rodríguez-Blanco N; Montero-Navarro S; Botella-Rico JM; Felipe-Gómez AJ; Sánchez-Más J; Tuells J
Int J Environ Res Public Health; 2021 May; 18(10):. PubMed ID: 34063476
[TBL] [Abstract][Full Text] [Related]
53. Attitudes towards Anti-SARS-CoV2 Vaccination among Healthcare Workers: Results from a National Survey in Italy.
Di Gennaro F; Murri R; Segala FV; Cerruti L; Abdulle A; Saracino A; Bavaro DF; Fantoni M
Viruses; 2021 Feb; 13(3):. PubMed ID: 33652829
[TBL] [Abstract][Full Text] [Related]
54. Vaccine confidence and hesitancy in Brazil.
Brown AL; Sperandio M; Turssi CP; Leite RMA; Berton VF; Succi RM; Larson H; Napimoga MH
Cad Saude Publica; 2018 Sep; 34(9):e00011618. PubMed ID: 30281705
[TBL] [Abstract][Full Text] [Related]
55. Enhancing COVID-19 Vaccines Acceptance: Results from a Survey on Vaccine Hesitancy in Northern Italy.
Reno C; Maietti E; Fantini MP; Savoia E; Manzoli L; Montalti M; Gori D
Vaccines (Basel); 2021 Apr; 9(4):. PubMed ID: 33924534
[TBL] [Abstract][Full Text] [Related]
56. A validated modification of the vaccine hesitancy scale for childhood, influenza and HPV vaccines.
Helmkamp LJ; Szilagyi PG; Zimet G; Saville AW; Gurfinkel D; Albertin C; Breck A; Vangala S; Kempe A
Vaccine; 2021 Mar; 39(13):1831-1839. PubMed ID: 33676784
[TBL] [Abstract][Full Text] [Related]
57. Vaccine nationalism: a predicament in ending the COVID-19 pandemic.
Lagman JDN
J Public Health (Oxf); 2021 Jun; 43(2):e375-e376. PubMed ID: 33730161
[TBL] [Abstract][Full Text] [Related]
58. Willingness to vaccinate against COVID-19 among Bangladeshi adults: Understanding the strategies to optimize vaccination coverage.
Abedin M; Islam MA; Rahman FN; Reza HM; Hossain MZ; Hossain MA; Arefin A; Hossain A
PLoS One; 2021; 16(4):e0250495. PubMed ID: 33905442
[TBL] [Abstract][Full Text] [Related]
59. Causes of Vaccine Hesitancy in Adults for the Influenza and COVID-19 Vaccines: A Systematic Literature Review.
Kumar S; Shah Z; Garfield S
Vaccines (Basel); 2022 Sep; 10(9):. PubMed ID: 36146596
[TBL] [Abstract][Full Text] [Related]
60. Resisting the "righting reflex" in conversations about covid vaccine hesitancy.
Easton GP
BMJ; 2021 Jun; 373():n1566. PubMed ID: 34155085
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
